178 related articles for article (PubMed ID: 26221207)
1. Reversing drug resistance of cisplatin by hsp90 inhibitors in human ovarian cancer cells.
Zhang Z; Xie Z; Sun G; Yang P; Li J; Yang H; Xiao S; Liu Y; Qiu H; Qin L; Zhang C; Zhang F; Shan B
Int J Clin Exp Med; 2015; 8(5):6687-701. PubMed ID: 26221207
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
3. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
5. [Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP].
Zhang X; Li N; Wang YH; Huang Y; Xu NZ; Wu LY
Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):174-7. PubMed ID: 19615253
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
He J; Li L; Tang BJ; Zhang W; Li DR; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):686-90. PubMed ID: 20079182
[TBL] [Abstract][Full Text] [Related]
7. Effect of tamoxifen, methoxyprogesterone acetate and combined treatment on cellular proliferation and apoptosis in SKOV3/DDP cells via the regulation of vascular endothelial growth factor.
Wen L; Hong D; Yanyin W; Mingyue Z; Baohua L
Arch Gynecol Obstet; 2013 May; 287(5):997-1004. PubMed ID: 23212665
[TBL] [Abstract][Full Text] [Related]
8. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
9. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].
Shi L; Yu H; Zhang W; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735
[TBL] [Abstract][Full Text] [Related]
10. [Effects of recombinant human interleukin-24 alone and in combination with cisplatin on the growth of ovarian cancer cells in vitro].
Wang S; Guo J; Tang Y; Zheng R; Song M; Sun W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jan; 30(1):33-6. PubMed ID: 24405596
[TBL] [Abstract][Full Text] [Related]
11. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
[TBL] [Abstract][Full Text] [Related]
12. [Reversal effect of Fe3O4-magnetic nanoparticles on multi-drug resistance of ovarian carcinoma cells and its correlation with apoptosis-associated genes].
Jiang Z; Chen BA; Wu Q; Xia GH; Zhang Y; Gao F; Hong TY; Xu CR; Cheng J; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
Ai Zheng; 2009 Nov; 28(11):1158-62. PubMed ID: 19895735
[TBL] [Abstract][Full Text] [Related]
13. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
Chen J; Wang Q; Zhang W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
[TBL] [Abstract][Full Text] [Related]
14. LDR reverses DDP resistance in ovarian cancer cells by affecting ERCC-1, Bcl-2, Survivin and Caspase-3 expressions.
Ju X; Yu H; Liang D; Jiang T; Liu Y; Chen L; Dong Q; Liu X
Biomed Pharmacother; 2018 Jun; 102():549-554. PubMed ID: 29597088
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
[TBL] [Abstract][Full Text] [Related]
16. TRIAP1 Inhibition Activates the Cytochrome c/Apaf-1/Caspase-9 Signaling Pathway to Enhance Human Ovarian Cancer Sensitivity to Cisplatin.
Zhang TM
Chemotherapy; 2019; 64(3):119-128. PubMed ID: 31661694
[TBL] [Abstract][Full Text] [Related]
17. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
18. Octreotide enhances the sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro.
Shen Y; Ren M; Shi Y; Zhang Y; Cai Y
Exp Ther Med; 2011 Nov; 2(6):1171-1176. PubMed ID: 22977639
[TBL] [Abstract][Full Text] [Related]
19. [Effects of methylseleninic acid on cisplatin-resistant ovarian cancer cells (SKOV3/DDP) and the mechanisms].
Tan Y; Feng Q; Sun X; Xue M; Jiang N; Deng X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1305-1311. PubMed ID: 28070043
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves the sensitivity of ovarian cancer cells to chemotherapeutic agents.
Yang C; Zhao N; Li D; Zou G; Chen Y
Oncol Lett; 2019 Sep; 18(3):2404-2411. PubMed ID: 31402943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]